Researchers examined trends in adherence to various treatment among patients with psoriasis using data from a large health insurance database. For which therapy had the highest odds for adherence, read more.

News

News
Friday, November 10, 2017
People with chronic inflammatory disorders like psoriasis and rheumatoid arthritis may have an increased risk of developing serious liver damage, a recent study suggests.
News
Wednesday, November 1, 2017
A recent study examined the impact of visceral fat on vascular inflammation in patients with psoriasis.
News
Monday, October 30, 2017
Members of the National Psoriasis Foundation’s medical board recently spoke with The Dermatologist to discuss the importance of the awareness day and its impact, as well as what patients and dermatologists can take away from the event. 
News
Friday, October 27, 2017
In an effort to increase awareness of psoriasis, The International Federation of Psoriasis Association has deemed October 29, 2017 to be World Psoriasis Day.

NPF Endorsed Articles

NPF Endorsed Articles
Tuesday, July 22, 2014
The link between psoriasis and other medical conditions such as psoriatic arthritis (PsA), cardiovascular disease, metabolic disorder, inflammatory bowel disease, psychiatric disorders, lymphoma and ocular disease is being recognized by a growing body of peer review literature. 

Research in Review

Research in Review
Thursday, February 11, 2016
In this excerpt from the recently published book, Practical Psoriasis Management, the authors discuss the use of secukinumab for moderate-to-severe psoriasis.   
Research in Review
Friday, December 18, 2015
A 5-year-old girl presented with a 3-week history of multiple discrete, pink, scaly plaques. The plaques were ovoid, ranged from 0.5 to 3 cm in diameter, and were slightly raised, blanchable, and pruritic.
Research in Review
Monday, June 15, 2015
Research in Review
Tuesday, April 21, 2015
Joel M. Gelfand, MD, MSCE, associate professor of dermatology and epidemiology, University of Pennsylvania Perelman School of Medicine, is co-chair of the Interdisciplinary Autoimmune Summit (IAS). In this interview, Dr. Gelfand fills The Dermatologist readers in on the importance of the IAS meeting, psoriasis research and more.